Butt Tausif 4
4 · ChemoCentryx, Inc. · Filed Mar 1, 2021
Insider Transaction Report
Form 4
Butt Tausif
EVP, Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-25+87,000→ 87,000 totalExercise: $65.87Exp: 2031-02-25→ Common Stock (87,000 underlying)
Footnotes (2)
- [F1]The option was granted on February 25, 2021, and 25% of the total number of shares of common stock subject to the option vests on February 23, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
- [F2]Not applicable.